Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2001	12-2000	09-2000	06-2000	03-2000
Assets
Current Assets
Cash & Cash Equivalents	18,440	22,708	N/A	N/A	N/A
Marketable Securities	13,532	15,493	N/A	N/A	N/A
Receivables	797	800	N/A	N/A	N/A
TOTAL	$32,769	$39,001	$N/A	$N/A	$N/A

Non-Current Assets
PPE Net	396	312	N/A	N/A	N/A
Investments And Advances	14,974	10,240	0	0	0
Other Non-Current Assets	764	711	0	0	0
TOTAL	$16,134	$11,263	$N/A	$N/A	$N/A

Total Assets	$48,902	$50,264	$N/A	$N/A	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	1,272	919	0	0	0
Accrued Expenses	326	174	N/A	N/A	N/A
TOTAL	$1,598	$1,093	$N/A	$N/A	$N/A

Non-Current Liabilities
Long Term Debt	412	304	N/A	N/A	N/A
TOTAL	$412	$304	$N/A	$N/A	$N/A

Total Liabilities	$2,010	$1,397	$N/A	$N/A	$N/A

Shareholders' Equity
Shares Outstanding, K	19,618	N/A	N/A	N/A	N/A
Common Shares	20	19	N/A	N/A	N/A
Retained earnings	-26,301	-23,913	N/A	N/A	N/A
Other shareholders' equity	-1,878	-3,805	0	0	0
TOTAL	$46,893	$48,867	$N/A	$N/A	$N/A

Total Liabilities And Equity	$48,903	$50,264	$0	$0	$0